What The Activism World Is Talking AboutGuest Post
Trian Partners had long been expected to seek a board seat at Procter & Gamble, and yesterday’s announcement of its nomination of Nelson Peltz confirmed that objective. The activist still claims to want to avoid a proxy fight but as at DuPont two years ago, it will pull out all the stops to get Peltz in the boardroom, where he will establish a new route for information to reach directors, push for non-executive sessions . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email firstname.lastname@example.org or click Chat.